ENvue Medical Faces Nasdaq Delisting After Stock Sinks Below $1 for 30 Days
FEED sits 25% above its 52-week low of $0.422.
Summary
ENvue Medical received a Nasdaq delisting notice on July 10, 2026, after its stock traded below $1 for 30 consecutive days. A prior reverse split makes the company ineligible for the usual compliance period, so it will appeal the decision, though the outcome is clouded by ongoing financial struggles.
Key Events · Legal and Risk Events · FEED
-
Nasdaq Delisting Notice Received
On July 10, 2026, ENvue Medical received a Staff Determination Letter from Nasdaq, citing that the stock closed below $1.00 for 30 consecutive business days—from May 26 through July 8, 2026—violating the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
-
Ineligible for Standard Compliance Period
A 1-for-10 reverse stock split on August 12, 2025, disqualifies the company from the standard 180-day grace period under Nasdaq rules, forcing an immediate appeal to the Nasdaq Hearings Panel to avert delisting.
-
Appeal to Nasdaq Hearings Panel Planned
The company intends to request a hearing before the Panel, which will stay any suspension or delisting action pending the Panel's decision. There is no assurance, however, that the appeal will be granted or that the company can regain compliance.
-
Deepening Financial Distress Context
This delisting notice follows a series of severe financial setbacks—including a going concern warning, a 391% increase in net loss, negative gross profit, and a $2.285 million arbitration loss—all disclosed in recent SEC filings.
Analysis · FEED · Industrial Applications And Services
Nasdaq has formally notified ENvue Medical that its stock fails the minimum $1 bid price rule, and a reverse split executed within the past year blocks the standard 180-day grace period. To avoid delisting, the company must now appeal to a Nasdaq hearings panel. This unfolds amid severe financial distress—a going concern warning, mounting losses, and a recent arbitration loss—making a successful appeal uncertain and heightening the risk of a move to the OTC markets, which would further erode liquidity and investor confidence.
At the time of this filing, FEED was trading at $0.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $0.42 to $17.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.